There are 2789 resources available
436P - Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
Presenter: Omar Saavedra Santa Gadea
Session: ePoster Display
437P - Quality of life (QoL) in patients (pts) with microsatellite instability (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) alone or in combination with ipilimumab (IPI): CheckMate 142
Presenter: Eric Van Cutsem
Session: ePoster Display
438P - First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study
Presenter: Bernard Asselain
Session: ePoster Display
439P - Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study
Presenter: John Strickler
Session: ePoster Display
440P - Response to BRAF inhibitors combined with anti-EGFR after previous anti-EGFR exposure for BRAF V600E mutant metastatic colorectal cancer patients
Presenter: Emilie Hafliger
Session: ePoster Display
317P - Survival analysis and prognostic factors in patients with metastatic breast cancer and oligometastatic disease
Presenter: Gema Marin Zafra
Session: ePoster Display
318P - Impact of right dose vs on-time chemotherapy on PFS in patients suffering from metastatic breast cancer
Presenter: Anudeep Padakanti
Session: ePoster Display
319P - A propensity score weighted study comparing two versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
Presenter: Herve Bischoff
Session: ePoster Display
320P - Prognostic role of meningeal carcinomatosis in breast cancer
Presenter: Renata Meneguetti
Session: ePoster Display
321P - Breast cancer in women younger than 40 years: Increasing proportion of new cases and deaths in Brazil
Presenter: Renata Bonadio
Session: ePoster Display